MOHNARK PHARMACEUTICALS INC.

Form 483 issued February 25, 2022 · Fort Pierce, Florida

Inspection
Feb 22 – Feb 25, 2022
Observations
5
Pages
5
FEI number
3015500516

In short: On February 25, 2022, FDA issued a Form 483 with 5 observations to MOHNARK PHARMACEUTICALS INC. in Fort Pierce, Florida (FEI 3015500516) after an inspection that ran Feb 22 – Feb 25, 2022. The investigators were Joanne E. King and Lillian M. Colon-Mcknight. Most observations concern facilities & equipment and quality system.

At a glance

Facilities & equipment and quality system account for 3 of 5 observations.

Facilities & equipment2
Quality system1
Materials1
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The quality control unit lacks responsibility to approve and reject all procedures or specifications impacting on…

  2. 02

    Reports of analysis from component suppliers are accepted in lieu of testing each component for conformity…

  3. 03

    The master production and control records lack an accurate statement of the weight and measure of…

  4. 04

    Equipment for adequate control over dust is not provided when appropriate for the manufacture, processing, packing…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at MOHNARK PHARMACEUTICALS INC.?

FDA listed 5 observations on this Form 483, mostly about facilities & equipment, quality system and materials. The opening words of each observation are shown on this page.

Who inspected MOHNARK PHARMACEUTICALS INC.?

Joanne E. King and Lillian M. Colon-Mcknight are named on this Form 483, for the inspection of Feb 22 – Feb 25, 2022. Each investigator has a profile showing what they cite most.

When was MOHNARK PHARMACEUTICALS INC. inspected by FDA?

The inspection ran Feb 22 – Feb 25, 2022, and the Form 483 is dated February 25, 2022.

How do I get the full Form 483 for MOHNARK PHARMACEUTICALS INC.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free